Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors.

Kevin C Conlon Dionysios C Watson Thomas A Waldmann Antonio Valentin Cristina Bergamaschi Barbara K Felber Cody J Peer William Douglas Figg E Lake Potter Mario Roederer Douglas G McNeel John A Thompson Sumati V Gupta Rom S Leidner Andrea Wang-Gillam Nehal S Parikh Debby Long Sema Kurtulus Lang Ho Lee Niladri Roy Chowdhury Florent Bender George N Pavlakis

Published in: Journal for immunotherapy of cancer (2022)

NCT02452268.

Keyphrases